FN2 Earnings Intelligence
Intuitive Surgical, Inc. balance sheet
Intuitive Surgical, Inc. (ISRG) Balance Sheet (annual) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - |
| - Cash | $1,290.9 | $1,581.2 | $2,750.1 | $2,027.4 | $3,368 |
| + Debt | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - |
| Revenue | $5,710.1 | $6,222.2 | $7,124.1 | $8,352.1 | $10,064.7 |
| % Growth | 31.0% | 9.0% | 14.5% | 17.2% | 20.5% |
| Gross Profit | $3,958.5 | $4,196 | $4,729.5 | $5,634.2 | $6,642.3 |
| % Margin | 69.3% | 67.4% | 66.4% | 67.5% | 66.0% |
| EBITDA | $2,101 | $1,903.1 | $2,148.8 | $2,787.9 | $3,545.5 |
| % Margin | 36.8% | 30.6% | 30.2% | 33.4% | 35.2% |
| Net Income | $1,704.6 | $1,322.3 | $1,798 | $2,322.6 | $2,856 |
| % Margin | 29.9% | 21.3% | 25.2% | 27.8% | 28.4% |
| Diluted EPS | $4.66 | $3.65 | $5.03 | $6.42 | $7.87 |
| % Growth | -47.2% | -21.7% | 37.8% | 27.6% | 22.6% |
| Operating Cash Flow | $2,089.4 | $1,490.8 | $1,813.8 | $2,415 | $3,030.5 |
| CapEx | $353.5 | $532.4 | $1,064.2 | $1,111.2 | $539.8 |
| Free Cash Flow | $1,735.9 | $958.4 | $749.6 | $1,303.8 | $2,490.7 |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue | $5,710.1 | $6,222.2 | $7,124.1 | $8,352.1 | $10,064.7 |
| Gross Profit | $3,958.5 | $4,196 | $4,729.5 | $5,634.2 | $6,642.3 |
| EBITDA | $2,101 | $1,903.1 | $2,148.8 | $2,787.9 | $3,545.5 |
| Net Income | $1,704.6 | $1,322.3 | $1,798 | $2,322.6 | $2,856 |
| Diluted EPS | $4.66 | $3.65 | $5.03 | $6.42 | $7.87 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1,290.9 | $1,581.2 | $2,750.1 | $2,027.4 | $3,368 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $2,089.4 | $1,490.8 | $1,813.8 | $2,415 | $3,030.5 |
| Capital Expenditure | $353.5 | $532.4 | $1,064.2 | $1,111.2 | $539.8 |
| Free Cash Flow | $1,735.9 | $958.4 | $749.6 | $1,303.8 | $2,490.7 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 31.0% | 9.0% | 14.5% | 17.2% | 20.5% |
| Gross Margin | 69.3% | 67.4% | 66.4% | 67.5% | 66.0% |
| EBITDA Margin | 36.8% | 30.6% | 30.2% | 33.4% | 35.2% |
| Net Margin | 29.9% | 21.3% | 25.2% | 27.8% | 28.4% |
| FCF Margin | 30.4% | 15.4% | 10.5% | 15.6% | 24.7% |
| Diluted EPS Growth | -47.2% | -21.7% | 37.8% | 27.6% | 22.6% |